IPP Bureau
Biocon Q4 profit jumps 64%; FY26 revenue crosses Rs. 16,900 crore
By IPP Bureau - May 08, 2026
Among the growth drivers are biosimilars business, operational efficiencies, and integration of biosimilars and generics operations
Dr. Reddy’s and Nestle Health Science launch Celevida GLP for optimized nutritional support
By IPP Bureau - May 08, 2026
Clinical guidelines and expert consensus recommend 1.2–1.5 g/kg/day protein intake during therapy to help preserve muscle mass
Lupin Q4 FY26 PBT jumps 115% to Rs 19,280 million
By IPP Bureau - May 08, 2026
U.S. business drives strong growth as Lupin reports 57% rise in Q4 U.S. sales and 43% increase in gross profit
Kalahandi gets a major healthcare boost as Vedanta launches 24x7 telemed service
By IPP Bureau - May 08, 2026
Initiative launched with Tata 1mg to benefit 70,000 people across 70 remote villages in Kalahandi region
Govt. launches JANANI platform to strengthen maternal and child healthcare tracking
By IPP Bureau - May 08, 2026
Digital platform records over 1.34 crore beneficiary registrations with QR-enabled MCH cards and real-time monitoring features
Thyrocare Q4 PAT surges 128% to Rs. 48.7 crore
By IPP Bureau - May 08, 2026
Diagnostic major processes 59 million tests in Q4FY26 as revenue rises 20% and specialty testing portfolio expands
Roche moves to acquire PathAI for up to $1.05 billion in major AI pathology push
By IPP Bureau - May 08, 2026
The acquisition positions Roche more aggressively in digital pathology and precision diagnostics capabilities
ICMR launches fellowship programme for biomedical scientists from developing countries
By IPP Bureau - May 08, 2026
Initiative aims to strengthen South-South collaboration and capacity building in biomedical research
Moderna’s mRNA flu vaccine outperforms standard shot in Phase 3 trial
By IPP Bureau - May 08, 2026
NEJM study shows strong protection across strains
Dabur profit jumps 16% as FMCG growth gains pace
By IPP Bureau - May 08, 2026
Hair care & quick commerce shine
Vijaya Diagnostic Q4FY26 revenue jumps 27%, EBITDA margin expands to 43.5%
By IPP Bureau - May 08, 2026
With robust FY26 growth, plans AI-led diagnostics and genomic testing expansion
World Thalassemia Day: RGCIRC promotes shift from transfusion to transplant
By IPP Bureau - May 08, 2026
The leading cancer hospital urges carrier screening to prevent thalassemia burden
MilliporeSigma lands exclusive 5-year deal to test Genetix Biotherapeutics gene therapies
By IPP Bureau - May 08, 2026
The deal positions MilliporeSigma at the center of commercial manufacturing for three breakthrough gene therapies targeting sickle cell disease, ?-thalassemia, and cerebral adrenoleukodystrophy
Sanofi India partners with NHM MP to expand NCD, rare disease services
By IPP Bureau - May 08, 2026
The partnership will focus on diabetes and NCD awareness, rare disease screening, and deployment of mobile medical units
Cirena licenses Agilent RNA purification tech to unlock high-purity long RNA for genome editing
By IPP Bureau - May 08, 2026
The agreement targets a long-standing technical hurdle in the field: maintaining chemical purity as RNA constructs extend beyond 100 nucleotides
